VNDA — Vanda Pharmaceuticals Inc. catalysts

3 verified catalyst event(s) for Vanda Pharmaceuticals Inc. (ticker VNDA). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onycho · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
READOUT
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Sev
Phase 2 · Onychomycosis of Toenail
VNDA Vanda Pharmaceuticals Inc. Trichostatin A ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09 (month)
in 2mo
ESTIMATED
READOUT
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to P
Phase 2 · Dry Eye
VNDA Vanda Pharmaceuticals Inc. VSJ-110 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10 (month)
in 3mo
ESTIMATED
READOUT
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participan
Phase 2 · Hypertension, Uncontrolled Hypertension
VNDA Vanda Pharmaceuticals Inc. iloperidone ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.